Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgenâs Neulasta to help reduce the risk of infection after intense chemotherapy.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļPODD
āļāļ·āđāļāļāļĢāļīāļĐāļąāļInsulet Corp
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļMay 15, 2007
āļāļĩāļāļĩāđāļMcevoy (Ashley)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ3900
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļMay 15
āļāļĩāđāļāļĒāļđāđ100 Nagog Park
āđāļĄāļ·āļāļACTON
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ01720-3440
āđāļāļĢāļĻāļąāļāļāđ19786007000
āđāļ§āđāļāđāļāļāđhttps://www.omnipod.com
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļPODD
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļMay 15, 2007
āļāļĩāļāļĩāđāļMcevoy (Ashley)
Dr. Jessica Hopfield, Ph.D.
Dr. Jessica Hopfield, Ph.D.
Independent Director
Mr. Michael R. Minogue
Independent Director
Mr. Eric Benjamin
Chief Operating Officer
Ms. Elizabeth H. (Bess) Weatherman
Ms. Elizabeth H. (Bess) Weatherman
Independent Director
Ms. Lauren Budden
Chief Accounting Officer, Group Vice President, Corporate Controller
Chief Accounting Officer, Group Vice President, Corporate Controller
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Independent Director
Ms. Laetitia Cousin
Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance
Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance
Mr. Prem Singh
Senior Vice President - Global Operations
Senior Vice President - Global Operations
Dr. Luciana Borio, M.D.
Independent Director
Mr. Timothy J. (Tim) Scannell
Mr. Timothy J. (Tim) Scannell
Independent Chairman of the Board
Independent Chairman of the Board
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Dr. Jessica Hopfield, Ph.D.
Dr. Jessica Hopfield, Ph.D.
Independent Director
Mr. Michael R. Minogue
Independent Director
Mr. Eric Benjamin
Chief Operating Officer
Ms. Elizabeth H. (Bess) Weatherman
Ms. Elizabeth H. (Bess) Weatherman
Independent Director
Ms. Lauren Budden
Chief Accounting Officer, Group Vice President, Corporate Controller
Chief Accounting Officer, Group Vice President, Corporate Controller
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Independent Director
Langar Global HealthTech ETF
Innovator IBD Breakout Opportunities ETF
Goldman Sachs Future Health Care Equity ETF
First Trust Nasdaq Lux Digi Health Solutions ETF
iShares Health Innovation Active ETF
iShares U.S. Medical Devices ETF
FT Raymond James Multicap Growth Equity ETF
Acruence Active Hedge US Equity ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Langar Global HealthTech ETF
āļŠāļąāļāļŠāđāļ§āļ7.26%
Innovator IBD Breakout Opportunities ETF
āļŠāļąāļāļŠāđāļ§āļ4.88%
Global X HealthTech ETF
āļŠāļąāļāļŠāđāļ§āļ4.76%
Goldman Sachs Future Health Care Equity ETF
āļŠāļąāļāļŠāđāļ§āļ4.2%
First Trust Nasdaq Lux Digi Health Solutions ETF
āļŠāļąāļāļŠāđāļ§āļ3.7%
iShares Health Innovation Active ETF
Congress SMid Growth ETF
āļŠāļąāļāļŠāđāļ§āļ2.82%
iShares U.S. Medical Devices ETF
āļŠāļąāļāļŠāđāļ§āļ2.62%
FT Raymond James Multicap Growth Equity ETF
āļŠāļąāļāļŠāđāļ§āļ2.3%
Acruence Active Hedge US Equity ETF
āļŠāļąāļāļŠāđāļ§āļ2.27%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
0.00
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē

āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ